Epalrestat Sustained Release Tablets 150mg PAN India Manufacturer & Global Exporter
Introduction – Leading Epalrestat 150mg Manufacturer in India
We are a globally recognized Epalrestat Sustained Release Tablets 150mg manufacturer, supplier, and exporter in India, delivering high-quality pharmaceutical formulations under the trusted brand EPATAJ. Our company is engaged in providing advanced therapeutic solutions for the effective management of diabetic neuropathy, a chronic condition caused by long-term diabetes.
With strong manufacturing capabilities in Vapi, Gujarat, India, and a robust marketing presence in Mumbai, Maharashtra, we have established ourselves as a reliable partner for healthcare providers, distributors, and pharma franchise businesses across PAN India and international markets.
Epalrestat Tablets 150mg – Advanced Solution for Diabetic Neuropathy
Epalrestat 150mg Sustained Release Tablets are widely used in the treatment of diabetic nerve damage. The active pharmaceutical ingredient works as an aldose reductase inhibitor, which helps reduce sorbitol accumulation in nerve tissues.
This mechanism supports:
- Reduction in nerve pain
- Relief from tingling and burning sensation
- Improved nerve function
- Prevention of further diabetic nerve damage
Our formulation ensures consistent therapeutic action, making it a preferred choice among physicians treating diabetic complications.
Mechanism of Action – Why Epalrestat is Effective
We develop Epalrestat Tablets (EPATAJ) based on clinically proven pharmacological mechanisms. In diabetic patients, excess glucose is converted into sorbitol, which accumulates in nerve cells and leads to neuropathic pain.
Epalrestat works by:
- Blocking aldose reductase enzyme activity
- Preventing sorbitol buildup in nerves
- Reducing oxidative stress in nerve tissues
- Improving nerve conductivity and regeneration support
This targeted action makes Epalrestat a key molecule in modern diabetic neuropathy management.
Sustained Release Technology – Enhanced Therapeutic Performance
We manufacture Epalrestat Sustained Release Tablets 150mg using advanced controlled-release technology. This ensures:
- Gradual release of medicine over time
- Long-lasting therapeutic effect
- Improved patient compliance with once-daily dosing
- Reduced fluctuation in drug concentration
- Better gastrointestinal tolerance
This innovative formulation enhances the overall effectiveness of diabetic neuropathy treatment.
Leading Manufacturer from Vapi, Gujarat & Mumbai Presence
We are strategically located in Vapi, Gujarat, one of India’s leading pharmaceutical manufacturing hubs. Additionally, we maintain strong business operations and distribution support in Mumbai, Maharashtra, ensuring smooth supply chain management across India.
Our infrastructure enables us to serve as:
- Epalrestat Tablets Manufacturer in India
- Epalrestat 150mg Supplier from Mumbai
- Epalrestat Manufacturer Vapi Gujarat
- Epalrestat Tablets Manufacturer & Supplier PAN India
This dual-location advantage allows us to efficiently serve domestic and international markets.
PAN India Supply Network & Distribution Strength
We maintain a strong distribution network across India, making us a trusted PAN India Epalrestat Tablets manufacturer and supplier.
Our supply chain covers:
- Metro cities
- Tier 1 and Tier 2 pharma markets
- Hospital supply chains
- Wholesale pharma distributors
- Retail pharmacy networks
We ensure uninterrupted availability of Epalrestat Sustained Release Tablets 150mg (EPATAJ) across all regions.
Global Export Markets – Africa, Middle East & LATAM
We are a fast-growing Epalrestat Tablets exporter from India, supplying high-quality formulations to global markets including:
- Africa
- Middle East
- Latin America (LATAM)
Our export services include:
- Regulatory documentation support
- Bulk export packaging
- Private labeling options
- Timely international delivery
- Compliance with global pharmaceutical standards
We aim to strengthen global diabetic care accessibility through reliable pharmaceutical exports.
PCD Pharma Franchise Opportunities with EPATAJ
We offer highly profitable PCD Pharma Franchise opportunities for Epalrestat 150mg Tablets across India.
Key benefits include:
- Monopoly-based marketing rights
- High demand diabetic product portfolio
- Strong brand support from EPATAJ
- Attractive profit margins
- Promotional and marketing assistance
Our franchise model is designed to support entrepreneurs and pharma distributors in building successful businesses in the diabetic care segment.
Quality Assurance & Manufacturing Excellence
We follow strict quality control systems to ensure premium pharmaceutical standards.
Our manufacturing process includes:
- WHO-GMP certified production facility
- High-grade raw material sourcing
- In-process quality checks
- Stability testing and validation
- Final product quality assurance
Every batch of Epalrestat Tablets 150mg is tested for safety, efficacy, and consistency before dispatch.
Dosage and Usage Guidelines
Epalrestat Sustained Release Tablets are generally prescribed as:
- Once daily administration
- Taken after meals
- Swallowed with water without crushing
Dosage may vary depending on patient condition and physician recommendation.
Safety Profile and Side Effects
Epalrestat is generally well tolerated. However, in some cases mild side effects may occur such as:
- Nausea
- Vomiting
- Mild abdominal discomfort
- Rare liver enzyme changes
These effects are usually temporary and resolve without intervention. Regular medical monitoring is recommended for long-term therapy.
Why Choose Us as Epalrestat 150mg Manufacturer in India?
We are a preferred choice in the pharmaceutical industry due to:
- Strong manufacturing infrastructure
- Competitive pricing and best market rates
- Reliable PAN India distribution
- Export excellence across multiple continents
- Ethical and transparent business practices
- Consistent product availability
Our brand EPATAJ is trusted for quality, affordability, and therapeutic reliability.
Epalrestat Tablets Best Price in Mumbai & India
We offer highly competitive pricing for Epalrestat Tablets 150mg in Mumbai and across Maharashtra, ensuring affordability without compromising quality.
Our pricing advantage helps:
- Pharma distributors increase margins
- Franchise partners grow faster
- Hospitals reduce procurement costs
- Export buyers achieve competitive market positioning
We ensure value-driven pharmaceutical supply solutions.
We are a leading Epalrestat Sustained Release Tablets 150mg manufacturer, exporter, and supplier in India, committed to delivering world-class pharmaceutical solutions for diabetic neuropathy management.
With strong manufacturing capabilities in Vapi, Gujarat, and operational excellence in Mumbai, Maharashtra, we serve both domestic and international markets with consistency and reliability.
Our brand EPATAJ represents quality, trust, and innovation in diabetic care pharmaceuticals, making us a preferred partner for distributors, wholesalers, and healthcare providers worldwide.
